As of 2025-09-13, the Fair Value of Medmix Ltd (MEDX.SW) is -0.68 CHF. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.14 CHF, the upside of Medmix Ltd is -106.69%.
With the market price of 10.14 CHF and our fair value calculation, Medmix Ltd (MEDX.SW) is not a good investment. Investing in MEDX.SW stocks now will result in a potential loss of 106.69%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 9.70 | 44.00 | 11.60 | 0.30 | -7.30 | 11.66 |
| YoY growth | -61.51% | 353.61% | -73.64% | -97.41% | -2,533.33% | -482.46% |
| Market Cap (mil) | 418.38 |
| P/E | |
| Forward P/E | 2,633.85x |
| EPS | -0.14 |
| Avg earnings growth rate | -482.46% |
| TTM earnings | -5.60 |